Advanced Search
  • May 3, 2016

    To mark World Asthma Day, Boston Scientific continues with our commitment to raise awareness of the devastating impact severe asthma can have. Severe asthma isn’t just ‘really bad asthma’,...

  • May 2, 2016
    “Despite my disease, I want to set things in motion, starting with myself!”

    On average about 48 kilometers – that is the distance that Tony Seidl will cycle every day during his eleven day tour from Altoetting, Germany to Padua, Italy. For most people this would already...

  • Apr 20, 2016
    European Approval Granted for Third-Generation System and All Previously Implanted, Second-Generation Systems

    Boston Scientific (NYSE: BSX) has received CE Mark approval for the new EMBLEM™ MRI Subcutaneous Implantable Defibrillator (S-ICD) System, as well as magnetic resonance (MR) conditional labeling...

  • Apr 11, 2016

    In recognition of James Parkinson's birthday, April 11th is celebrated globally as World Parkinson's Day. Parkinson’s disease (PD) is a chronic progressive neurological disorder which affects...

  • Feb 22, 2016
    First polymer-based, drug-eluting stent designed to treat peripheral lesions above the knee approved in Europe; IMPERIAL trial initiated to seek regulatory approvals in U.S. and Asia

    Boston Scientific (NYSE: BSX) today announced that the Eluvia™ Drug-Eluting Vascular Stent System has received CE Mark and is commencing commercialization immediately in the European Union and...

Show 5102550100 per page